Evidence map›Paper›PMID 26517878›Full record

ArticlePloS one2015

The Role of Long Polar Fimbriae in Escherichia coli O104:H4 Adhesion and Colonization.

Brittany N Ross, Maricarmen Rojas-Lopez, Roberto J Cieza, Brian D McWilliams, Alfredo G Torres

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. MappingAntibiotics (Basel, Switzerland) · 2026
    Article
  2. EnteroaggregativeEcoSal Plus · 2025
    Review
  3. Article
  4. FEMS microbes · 2024
    Article
  5. Shiga-Toxin-Producing Strains ofMicroorganisms · 2023
    Article
  6. Genomic insights ofFrontiers in microbiology · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Genetic and Virulence Profiles of EnteroaggregativeFrontiers in cellular and infection microbiology · 2020
    Article
  11. BioMed research international · 2020
    Article
  12. mSphere · 2019
    Article
  13. GenotoxicComparative medicine · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Shiga Toxin (Verotoxin)-producingFood safety (Tokyo, Japan) · 2017
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Brittany N RossDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, 77555-1070, United States of America.
Maricarmen Rojas-LopezDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, 77555-1070, United States of America.
Roberto J CiezaDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, 77555-1070, United States of America.
Brian D McWilliamsDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, 77555-1070, United States of America.
Alfredo G TorresDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, 77555-1070, United States of America; Department of Pathology and Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, Texas, 77555-1070, United States of America.
The University of Texas Medical Branch at Galveston · US

Funding

Long Polar Fimbriae of Attaching and Effacing Escherichia coliR01AI079154 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI TORRES, ALFREDO G · 2009 to 2013
$1.9M
NIAID NIH HHS AI079154NIAID NIH HHS R01 AI079154
6 · The paper itself

Abstract

A renewed interest in Shiga toxin-producing Escherichia coli (STEC) strains was sparked due to the appearance of an outbreak in 2011, causing 3,816 diarrheal cases and some deaths in Europe. The causative strain was classified as enteroaggregative E. coli of serotype O104:H4 that had acquired Shiga toxin genes. The ability of STEC O104:H4 to cause disease relies greatly on the bacteria's capacity to colonize, persist, and produce Shiga toxin. However, not much is known about the colonization factors of this strain. Because long polar fimbriae (lpf) lpf1 and lpf2 operons encode important colonization factors in other STEC isolates and E. coli O104:H4 possesses both loci, we hypothesized that Lpf is required for adhesion and colonization. In this study, isogenic lpfA1 and lpfA2 major fimbrial subunit mutants were constructed. To determine their role in O104:H4's virulence, we assessed their ability to adhere to non-polarized and polarized intestinal epithelial cells. The ΔlpfA1 showed decreased adherence in both cell systems, while the ΔlpfA2 only showed a decrease in adherence to polarized Caco-2 cells. We also tested the O104:H4 mutants' ability to form biofilm and found that the ΔlpfA1 was unable to form a stable biofilm. In an in vivo murine model of intestinal colonization, the ΔlpfA1 had a reduced ability to colonize the cecum and large intestine, consistent with the in vitro data. Further, we tested the lpfA1 mutants' ability to compete against the wild type. We found that in the in vitro and in vivo models, the presence of the wild type O104:H4 facilitates increased adherence of the ΔlpfA1 to levels exceeding that of the wild type. Overall, our data demonstrated that Lpf1 is one of the factors responsible for O104:H4 intestinal adhesion and colonization.

Indexed as

Bacterial AdhesionAnimalsBiofilmsCaco-2 CellsCecumEscherichia coliEscherichia coli ProteinsFimbriae, BacterialFimbriae ProteinsHumansJejunumMiceMice, Inbred ICRVirulenceEscherichia coli ProteinsFimbriae ProteinsLpfA1 protein, E coliLpfA2 protein, E coli

Identifiers

PMID26517878
PMCPMC4636846
OpenAlexW1927312046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.